Drug recall · December 13, 2023
SANDIMMUNE Oral Solution recall
Why: Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manufactured by: DELPHARM Huningue S.A.S., Huningue, France, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936. NDC 0078-0110-22
- Lots / codes
Lot #: FX001500, FX001582, Exp. 09/30/2024
- Quantity
- 6,997 bottles
- Company
- Novartis Pharmaceuticals Corporation, East Hanover, NJ
- Distribution
- Nationwide within the United States
- Initiated
- November 22, 2023 · Voluntary: Firm initiated
- Classified
- December 7, 2023
- Reported
- December 13, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cyclosporine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.